4//SEC Filing
WILLIAMS DOUGLAS E 4
Accession 0000899243-23-005695
CIK 0001659352other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:32 PM ET
Size
14.4 KB
Accession
0000899243-23-005695
Insider Transaction Report
Form 4
WILLIAMS DOUGLAS E
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2022-08-16+22,969→ 41,146 total - Sale
Common Stock
2022-08-17$2.21/sh−7,112$15,739→ 34,034 total - Sale
Common Stock
2023-02-17$0.59/sh−7,681$4,549→ 49,322 total - Exercise/Conversion
Restricted Stock Units
2022-08-16−22,969→ 68,906 total→ Common Stock (22,969 underlying) - Exercise/Conversion
Common Stock
2023-02-16+22,969→ 57,003 total - Exercise/Conversion
Restricted Stock Units
2023-02-16−22,969→ 45,937 total→ Common Stock (22,969 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On February 16, 2022, the reporting person was granted 91,875 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.
Documents
Issuer
Codiak BioSciences, Inc.
CIK 0001659352
Entity typeother
Related Parties
1- filerCIK 0001184847
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:32 PM ET
- Size
- 14.4 KB